Jason Zhou was appointed to lead the newly created CR-CP Life Science Fund in 2019, which was sponsored by China Resources Group and Charoen Pokphand Group. Previously, he served in China Resource Group as the strategy director of the healthcare business sector since 2012. In addition to his management and operational responsibilities, Dr Zhou intensively…
Top pedigree investments, IPOs and trade sales over 19 years with Andera Partners.
Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.
Founded and led Arrow Therapeutics Ltd to $150 million acquisition by AstraZeneca.
Highest quality investments including successful public listings of Orphazyme (ORPHA) and ObsEva (OBSV).